Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Myriad Genetics (MYGN) over the last 15 years, with Q3 2025 value amounting to 1.17.

  • Myriad Genetics' Asset Utilization Ratio rose 5446.65% to 1.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.17, marking a year-over-year increase of 5446.65%. This contributed to the annual value of 0.77 for FY2024, which is 1995.73% up from last year.
  • Myriad Genetics' Asset Utilization Ratio amounted to 1.17 in Q3 2025, which was up 5446.65% from 0.99 recorded in Q2 2025.
  • Myriad Genetics' 5-year Asset Utilization Ratio high stood at 1.17 for Q3 2025, and its period low was 0.52 during Q1 2021.
  • Over the past 5 years, Myriad Genetics' median Asset Utilization Ratio value was 0.62 (recorded in 2021), while the average stood at 0.68.
  • In the last 5 years, Myriad Genetics' Asset Utilization Ratio plummeted by 1125.63% in 2022 and then skyrocketed by 5446.65% in 2025.
  • Over the past 5 years, Myriad Genetics' Asset Utilization Ratio (Quarter) stood at 0.52 in 2021, then increased by 8.25% to 0.56 in 2022, then grew by 16.59% to 0.66 in 2023, then grew by 21.05% to 0.79 in 2024, then surged by 47.85% to 1.17 in 2025.
  • Its Asset Utilization Ratio stands at 1.17 for Q3 2025, versus 0.99 for Q2 2025 and 0.82 for Q1 2025.